Categories: India

UPDATE 1-CSL strikes rare disease drug deal worth up to $1.6 billion with Swiss firm Alentis

(Adds more details and background from paragraph 2 onwards) Oct 5 (Reuters) – Australia's CSL said on Monday it had entered into an agreement with Switzerland-based Alentis Therapeutics to co-develop

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

Stocks rise after Anthropic IPO pricing sets stage for blockbuster debut

By Ankur Banerjee SINGAPORE, Nov 19 (Reuters) - Asian stocks slid on Thursday as fears…

2 minutes ago

As criticism mounts, Trump administration says tech outages not coordinated

By Doina Chiacu and Alexandra Alper WASHINGTON, Nov 18 (Reuters) - The top US intelligence…

3 minutes ago

WRAPUP 2-Trump says historic summit with Xi, Putin already a 'win' before event

(Adds Xi, Putin, Trump speeches at APEC in paragraphs 8-11) * Trump says warm welcome…

7 minutes ago

GLOBAL MARKETS-Asian stocks fail to get a lift from Anthropic's IPO pricing

* Anthropic blockbuster IPO pricing fails to lift Asian stocks * US stock futures gain…

12 minutes ago

Asian stocks fail to get a lift from Anthropic's IPO pricing

By Ankur Banerjee SINGAPORE, Nov 19 (Reuters) - Asian stocks slid on Thursday as fears…

13 minutes ago

As criticism mounts, Trump administration says tech outages not coordinated

By Doina Chiacu and Alexandra Alper WASHINGTON, Nov 18 (Reuters) - The top US intelligence…

14 minutes ago